Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$9.38 - $20.29 $2,495 - $5,397
266 New
266 $5,000
Q2 2022

Aug 11, 2022

BUY
$10.12 - $23.32 $2,691 - $6,203
266 New
266 $3,000
Q1 2022

Apr 29, 2022

SELL
$19.54 - $33.59 $5,197 - $8,934
-266 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$22.51 - $36.79 $5,987 - $9,786
266 New
266 $9,000

Others Institutions Holding OPNT

About OPIANT PHARMACEUTICALS, INC.


  • Ticker OPNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,164,150
  • Description
  • Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...
More about OPNT
Track This Portfolio

Track Core Cap Advisors, LLC Portfolio

Follow Core Cap Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.